INSYTE with SurePlanTM LiverY90
INSYTE with SurePlanTM LiverY90
Collaboration between Sirtex Medical and MIM Software Inc. advances innovation and increases precision of liver-directed oncology therapies for patients.
MIM Software Inc. is the legal manufacturer of the SurePlan LiverY90 Software.
SurePlan is a trademark of MIM Software Inc.
SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of:
- Unresectable hepatocellular carcinoma (HCC), or
- Unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy, or
- Unresectable intrahepatic cholangiocarcinoma (iCCA), or
- Hepatic metastases by neuroendocrine tumours (mNET), or
- Other liver metastases